PUBLICATIONS
Publications from the PanCareSurPass project
PanCareSurPass is an EU-funded project looking at how to more widely implement the digital Survivorship Passport (SurPass) to improve survivorship care for survivors of childhood and adolescent cancer in Europe. PanCareSurPass developed, tested and implemented the SurPass in participating countries and will develop material to support implementation in other countries
Title | Authors | Link | PLAIN language summary | |
---|---|---|---|---|
Factors Influencing Implementation of the Survivorship Passport: The IT Perspective | Chronaki C et al. | Stud Health Technol Inform. 2022 May 16;293:161-168. https://doi.org/10.3233/SHTI220363 |
||
Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study | van den Oever S et al. | J. Cancer Survivorship 2023;164. https://doi.org/10.1007/s11764-023-01335-y |
PLAIN summary | |
Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study | de Beijer IAE et al. | J. Cancer Survivorship 2023. https://doi.org/10.1007/s11764-023-01498-8 |
PLAIN summary | |
European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guideline | de Beijer IAE et al. | J. Cancer Survivorship 2023. https://doi.org/10.1007/s11764-023-01493-z |
||
Scaling up and implementing the digital Survivorship Passport tool in routine clinical care – The European multidisciplinary PanCareSurPass project | Filbert AL et al. | Eur. J. Cancer 2024. https://doi.org/10.1016/j.ejca.2024.114029 |
Publications from the PanCareFollowUp project
PanCareFollowUp was an EU-funded project looking at how to best deliver survivorship care to survivors of childhood and adolescent cancer in Europe. The aim of PanCareFollowUp was to deliver care according to recently developed guidelines using an innovative model for person centred care that empowers survivors and supports self-management.
Title | Authors | Link | PLAIN language summary | |
---|---|---|---|---|
Efficacy of the PanCareFollowUp eHealth Lifestyle Intervention for Survivors of Childhood, Adolescent and Young Adult Cancer | van den Oever et al. | Cancer Medicine 2025, 14:e70694. https://doi.org/10.1002/cam4.70694 | PLAIN summary | |
Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: A systematic review | de Beijer et al. | Cancer Medicine 2024, 13(12):e7361. https://doi.org/10.1002/cam4.7361 | PLAIN summary | |
From long-term follow-up Recommendations for clinical practice to plain language summaries for childhood, adolescent, and young adult cancer survivors | van den Oever et al. | EJC Paediatric Oncology 2024 3 100165 https://doi.org/10.1016/j.ejcped.2024.100165 |
PLAIN summary | |
Healthcare providers’ expected barriers and facilitators to the implementation of person‐centered long‐term follow‐up care for childhood cancer survivors: A PanCareFollowUp study | Breij et al. | Cancer Medicine 2024, 13(20), e70225. https://doi.org/10.1002/cam4.70225 | PLAIN summary | |
Perceived barriers and facilitators to health behaviors in European childhood cancer survivors | Bouwman E et al. | Cancer Medicine 2023, 12(11): 12035-12959 | PLAIN summary | |
Healthcare professionals’ perceived barriers and facilitators of health behavior support provision: A qualitative study | Bouwman E et al. | Cancer Medicine. 2023;12:7414–7426. | PLAIN summary | |
Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study | Bouwman E et al. | Pilot and Feasibility Studies (2022) 8:260 | PLAIN summary | |
Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol | van Kalsbeek RJ et al. | BMJ Open 2022;12:e063134. | PLAIN summary | |
The PanCareFollowUp Care Intervention: A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer | van Kalsbeek RJ et al. | European Journal of Cancer 162; Feb 2022; 34 – 44 | PLAIN summary | |
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer | van Kalsbeek RJ et al. | European Journal of Cancer 154; Sep 2021; 316 – 328 | PLAIN summary | |
The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers | van Kalsbeek RJ et al. | European Journal of Cancer 153; Aug 2021; 74 – 85 | PLAIN summary |
PLAIN summary of ...
Why is this paper important?
The number of people surviving childhood cancer is growing. Unfortunately, these survivors face increased health risks due to the effects of their cancer treatment, so-called “late effects”. Therefore, to help manage these late effects, it’s important that survivors have access to long-term follow-up care tailored to their specific needs. To make this type of care available across Europe, the PanCareFollowUp consortium developed the PanCareFollowUp Care program. This program aims to provide personalised, evidence-based care for survivors based on their individual health risks. However, actually putting this program into practice can be challenging. For it to be successful, it’s important to understand any obstacles or helping factors that may affect its rollout. This paper discusses the obstacles and helping factors that healthcare providers expect when rolling out the PanCareFollowUp Care program.
What did we do?
We conducted four focus group interviews with 30 healthcare providers working at PanCareFollowUp survivorship care centers in Belgium, the Czech Republic, Italy, and Sweden. In these interviews, open-ended questions were asked about the obstacles and helping factors healthcare providers expect when working with the PanCareFollowUp Care program. Participants included doctors, nurses, psychologists and physiotherapists who regularly work with childhood cancer survivors. We recorded and typed out each interview, then highlighted every obstacle or helping factor that healthcare providers mentioned. Next, we combined similar points into broader groups. Finally, we organized these groups using a framework by Grol & Wensing, which researchers often use to understand how programs are put into practice. This framework looks at six areas that can affect how a program rolls out: the program itself (innovation), the (healthcare) professionals, the patients, social factors, the organization, and economic or political factors.
What is the impact?
Most obstacles were at the organizational level, like not enough staff, time, capacity, and psychosocial support. Other important obstacles were too little knowledge of late effects among healthcare providers outside the late effects follow-up care team, the questionnaire belonging to the program which may be too difficult for survivors, and a lack of money. Key helping factors included motivated healthcare providers and survivors, a skilled hospital team, partnerships with general practitioners and psychosocial care facilities, using international collaboration, and sharing results to gain support from hospital managers. Our findings showed that we should pay special attention to knowledge, capacity, and financial issues, as well as address the psychosocial needs of survivors.
PLAIN summary of ...
Why is this paper important?
Childhood, adolescent, and young adult (CAYA) cancer survivors face increased risks of long-term health problems. Unhealthy habits—such as not exercising, smoking, poor diet, drinking too much alcohol, and not using sun protection—can further increase these risks. Programs that encourage healthy lifestyle changes can help reduce these risks and are practical to implement. To create effective support and intervention programs, it is important to understand what helps (facilitators) or hinders (barriers) these survivors in adopting healthier behaviors.
What did we do?
We systematically reviewed the existing research on the health behaviour of CAYA cancer survivors. The review included studies of people who were diagnosed with cancer at the age of 25 or younger, who were at least two years after their diagnosis, and who were between the ages of 16 and 50 at the time of the study. The review focused on behaviours such as physical activity, smoking, diet, alcohol consumption, sun exposure and general health habits. Of the 4,529 studies reviewed, 27 met our criteria. The total study group involved 31,905 participants.
What is the impact?
- Physical Activity: Common barriers included fatigue, lack of motivation, time constraints, and current smoking habits. Facilitators were perceived health benefits and personal motivation.
- Smoking: A supportive social environment and poor mental health were associated with increased smoking, whereas increased energy levels were linked to reduced smoking.
- General Health Behaviors: Barriers encompassed unmet information needs and time constraints. Conversely, lifestyle advice and discussions with healthcare professionals served as facilitators.
- Demographic Factors: Women were more likely to be physically inactive but less likely to consume alcohol and more likely to adhere to sun protection recommendations compared to men. Higher education levels were associated with increased physical activity, while lower education levels correlated with higher smoking rates.
- No relevant barriers and facilitators were identified for diet, alcohol consumption, and sun exposure
These results help us understand what affects health habits in CAYA cancer survivors. It identifies challenges and supports that influence their choices, which can help create better programs and guidance to improve healthy habits. It also helps healthcare providers support those most at risk for unhealthy habits.
PLAIN summary of ...
Why is this paper important?
It is important for survivors of childhood, adolescent, and young adult (CAYA) cancer to have sufficient knowledge of their cancer diagnosis, treatment, and risks for late effects. If survivors have sufficient knowledge, it is easier for them to recognise when they are experiencing symptoms and signs of late effects and need to contact their doctor. Also, it is important for survivors to understand their health risks and what they can do to reduce these risks, for example by improving their lifestyle.
As part of the European PanCareFollowUp project, 40 recommendations were developed for late effects screening. These recommendations instruct survivorship care doctors on the clinical tests that are needed for each of their patients. However, for survivors, these recommendations are very difficult to read. To create informational materials that provide more context and suit the needs of survivors, these recommendations were converted to 45 lay language summaries. The methodology for converting these recommendations to summaries is decribed in this paper.
What did we do?
We aimed for each of the 45 summaries to be Person-centred, written in Lay language, Accessible, Internationally relevant, and Navigable (PLAIN). Twenty-one doctors, researchers, guideline experts, and professional survivor representatives (the PanCare PLAIN Information Group) collaborated on translating the recommendations to summaries for survivors. First, the PLAIN Information Group decided on the structure and content for each summary, after which the summaries were drafted one by one. Each summary was subjected to two review rounds within the PLAIN Information Group, and one review round with external experts, survivors, and survivors’ parents/caregivers. The final summaries provide information about late effects, personal health risks, important symptoms and signs, recommended surveillance strategies, possible referral and treatment options, and self-care.
What is the impact?
The PLAIN language summaries are meant to increase knowledge in survivors and their families, while they may also inform doctors that provide late effects care. Along with their translations into other languages, the PLAIN summaries were made available on the PanCare website. In addition, a link to the summaries will be provided on the European Network of Youth Cancer Survivors information platform. Lastly, the summaries will be integrated into the Survivorship Passport, a clinical tool which is currently being implemented in many late effects clinics across Europe.
PLAIN summary of ...
Why is this paper important?
Survivors of childhood, adolescent, and young adult (CAYA) cancer may prevent or reduce the severity of late effects by living a healthy lifestyle, which includes sufficient physical exercise and a healthy diet. However, adopting healthier behaviours is challenging, especially for survivors dealing with barriers such as chronic fatigue or physical limitations. Earlier studies have shown that there is a need among survivors to receive tailored support in improving their lifestyle.
What did we do?
As part of the European PanCareFollowUp project, an online lifestyle coaching program was developed to support survivors in improving their lifestyle. During this program, 58 survivors received four months of individual lifestyle coaching during which they worked on a personal lifestyle goal (for example, lose 3 kg of weight, or train for a 5 km run). Another four months after their last coaching session, the lifestyle coach followed up with the survivors during a reflection session, during which the coach and survivor discussed progress and how the improved lifestyle behaviours could be maintained in the future. The coachings were conducted by certified coaches who recevied additional education about adopting a healthy lifestlyle for survivors of childhood, adolescent, and young adult (CAYA) cancer.
With this study, we aimed to assess the efficacy, or successfulness, of this online lifestyle coaching program. To measure this, we studied how many survivors were able to achieve their personal lifestyle goal within four months of coaching, and how many survivors were able to maintain this goal during the subsequent four months of follow-up. In addition, we studied the effects of this coaching program on survivors’ body mass index (BMI), diet, and physical activity.
What is the impact?
The results showed that online lifestyle coaching is successful in supporting the majority of CAYA cancer survivors in adopting healthier behaviours, as about two-thirds of the participants was able to achieve their personal lifestyle goal within the four months coaching period and sustain it thereafter during thethe additional four month follow-up period. Moreover, coaching supported them successfully in reducing their body mass index (BMI), improving the quality of dietary intake and increasing the amount of physical activity. However, the results suggest that this coaching program was less successful for survivors who had higher BMI’s or were coping with depressive feelings before start of the coaching sessions. These findings can be used to inform future studies on individual / personal online lifestyle coaching by a certified lifestyle trained in coach, and to integrate it into everyday survivorship care.
Publications from the PanCareLIFE project
PanCareLIFE was a 5-year (2013-8) EU Framework 7 Programme in the Health Theme that studied the impact of treatment regimes on the long-term health of childhood cancer survivors. Specifically, PanCareLIFE evaluated the risks of impairments in female fertility, in hearing, and in quality of life. PanCareLIFE also developed two guidelines for fertility preservation, and will disseminate widely the results from this project. Below an overview of publications that were made within the PanCareLIFE project.
Title | Authors | Link | |
---|---|---|---|
Genetic variation in gonadal impairment in female survivors of childhood cancer: design of a PanCareLIFE study. | van der Kooi ALF et al. | BMC Cancer 18, 930. https://doi.org/10.1186/s12885-018-4834-3 |
|
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity, and health related quality of life after cancer occurring among children and adolescents. | Byrne J et al. | Eur J Cancer 103, 227-237, 2018. https://doi.org/10.1016/j.ejca.2018.08.007 |
|
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE). | van den Berg M et al. | JMIR Res Protoc 7, e10824, 2018. https://doi.org/10.2196%2F10824 |
|
Genetic determinants of ototoxicity during and after childhood cancer treatment: protocol for the PanCareLIFE study. | Clemens E et al. | JMIR Res Protoc 8, e11868, 2019. https://doi.org/10.2196%2F11868 |
|
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. | Clemens E et al. | Pharmacogenomics J 20, 294–305, 2020. https://doi.org/10.1038/s41397-019-0113-1 |
|
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. | Langer T et al. | Data in Brief 32:106227, 2020. https://doi.org/10.1016/j.dib.2020.106227 |
|
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. | Langer T et al. | Eur J Cancer. 138, 212-224, 2020. https://doi.org/10.1016/j.ejca.2020.07.019 |
|
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function, | van der Kooi ALF et al. | Human Reproduction deaa342, 2021. https://doi.org/10.1093/humrep/deaa342. |
|
Health-related quality of life in European childhood cancer survivors: protocol for a study within PanCareLIFE . | Calaminus G et al. | JMIR Res Protoc 2021, 10: e21851 https://doi.org/10.2196/21851 |
|
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE). | van den Berg H et al. | Human Reproduction 0:1–13. 2021. https://doi.org/10.1093/humrep/deab035 |
|
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. | Mulder RL et al. | The Lancet Oncology 22, e45 – e56, 2021. https://doi.org/10.1016/S1470-2045(20)30594-5 |
|
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. | Mulder RL et al. | The Lancet Oncology 22, e57 – e67, 2021. https://doi.org/10.1016/S1470-2045(20)30582-9 |
|
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. | Mulder RL et al. | The Lancet Oncology 22, e68 – e80, 2021. https://doi.org/10.1016/S1470-2045(20)30595-7 |
|
Managing a pan-European consortium on late effects among long-term survivors of childhood and adolescent cancer – the PanCareLIFE project. | Kaatsch P et al. | Int J Environ Res Public Health 2021, 18, 3918. https://doi.org/10.3390/ijerph18083918. |
|
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. | Meijer AJM et al. | NPJ Precision Oncology; 5:64: February 2021. https://doi.org/10.1038/s41698-021-00178-z |
|
Fertility-Related Wishes and Concerns of Adolescent Cancer Patients and Their Parents. | Korte E et al. | J Adolesc Young Adult Oncol. 2020 Feb;9(1):55-62. https://doi.org/10.1089/jayao.2019.0064 |
|
Fertility education for adolescent cancer patients: Gaps in current clinical practice in Europe. | Korte E et al. | Eur J Cancer Care 2020 Sep. Sep;29(5):e13279. https://doi.org/10.1111/ecc.13279 |
|
Fertility knowledge and associated empowerment following an educational intervention for adolescent cancer patients. | Borgmann-Staudt A et al. | Psychooncology. 2019 Nov;28(11):2218-2225. https://doi.org/10.1002/pon.5210 |
|
Determinants of utilization of cryopreservation of germ cells in adolescent cancer patients in four European countries. | Balcerek M et al. | Eur J Pediatr. 2020 Jan;179(1):51-60. https://doi.org/10.1007/s00431-019-03459-9 |
|
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity, and health related quality of life after cancer occurring among children and adolescents. | Byrne J et al. | Eur J Cancer 103, 227-237, 2018. https://doi.org/10.1016/j.ejca.2018.08.007 |
|
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE). | van den Berg M et al. | JMIR Res Protoc 7, e10824, 2018. http://doi.org/10.2196/10824 |
|
Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers | Weiss A et al. | Qual Life Res 28, 515–521 (2019). https://doi.org/10.1007/s11136-018-2021-2 |
|
Europäische PanCare-Studien zu Spätfolgen nach Krebs im Kindes- und Jugendalter | Grabow D et al. | Onkologe 24, 754–759 (2018). https://doi.org/10.1007/s00761-018-0449-1 |
|
The influence of genetic variation on late toxicities in childhood cancer survivors | Clemens E et al. | Critical Reviews in Oncology / Hematology 126 (2018) 154–167 https://doi.org/10.1016/j.critrevonc.2018.04.001 |
|
Audiological monitoring in Swiss childhood cancer patients | Weiss A et al. | Pediatric Blood & Cancer, 10.1002/pbc.26877, 65, 3, (2017). https://doi.org/10.1002/pbc.26877 |
|
Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors | Clemens E et al. | Pediatric Hematology and Oncology, 34(2), 120–129. https://doi.org/10.1080/08880018.2017.1323985 |
|
Socio-demographic impact of platinum-induced ototoxicity in long-term survivors of childhood cancer | Clemens E et al. | Curr Pediatr Res 2017; 21 (3): 470-479 https://www.researchgate.net/publication/325170052_Socio-demographic_impact_of_platinum-induced_ototoxicity_in_long-term_survivors_of_childhood_cancer |
|
Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study | Weiss A et al. | PLoS ONE 12 (3): e0174479. | |
Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study | Clemens et al. | Eur J Cancer 2016 69:77-85 | |
Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss | Van der Kooi ALF et al. | Hum Reprod 2017 32:193-200 | |
Fertility preservation in children, adolescents and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations | Font-Gonzalez A et al. | Cancer 2016: Cancer 2016 122(14):2216-23 https://doi.org/10.1002/cncr.30047 |
Publications from the PanCareSurFup project
PanCareSurFup (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies) was a consortium of 16 European institutions in 11 countries, funded by the 7th Framework Programme of the EC, and carried out research studies into late effects of treatment for cancer, established guidelines for follow-up, and disseminated the results and provided training and workshops for stakeholders..
Title | Authors | Link | |
---|---|---|---|
Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group. | Michel G et al. | J Cancer Surviv. 2019 Oct;13(5):759-772. https://doi.org/10.1007/s11764-019-00795-5 |
|
Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. | Clement SC et al. | Cancer Treat Rev. 2018 Feb;63:28-39. https://doi.org/10.1016/j.ctrv.2017.11.005 |
|
The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. | yrne J et al. | Eur J Cancer. 2018 Nov;103:238-248. https://doi.org/10.1016/j.ejca.2018.08.017 |
|
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. | Skinner R et al. | Lancet Oncol. 2017 Feb;18(2):e75-e90. https://doi.org/10.1016/S1470-2045(17)30026-8 |
|
Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study. | Feijen EAM et al. | Heart. 2021 Jan;107(1):33-40. https://doi.org/10.1136/heartjnl-2020-316655 |
|
The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. | Grabow D et al. | Eur J Epidemiol. 2018 Mar;33(3):335-349. https://doi.org/10.1007/s10654-018-0370-3 |
|
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium. | van Dorp W et al. | J Clin Oncol. 2016 Oct 1;34(28):3440-50. https://doi.org/10.1200/JCO.2015.64.3288 |
|
Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. | Reulen RC et al. | Gut. 2020 Nov 2:gutjnl-2020-322237. https://doi.org/10.1136/gutjnl-2020-322237 |
|
Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. | Allodji RS et al. | Eur J Cancer. 2019 Aug;117:71-83 https://doi.org/10.1016/j.ejca.2019.05.013 |
|
Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup. | Feijen EA et al. | PLoS One. 2016 Sep 19;11(9):e0162778. https://doi.org/10.1371/journal.pone.0162778 |
|
Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort. | Wang Y et al. | Eur J Cancer. 2022 Apr;165:27-47. https://doi.org/10.1016/j.ejca.2022.01.001 |
|
Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. | Byrne J et al. | Int J Cancer. 2022 Feb 1;150(3):406-419. https://doi.org/10.1002/ijc.33817 |
|
The ‘Survivorship Passport’ for childhood cancer survivors. | Haupt R et al. | Eur J Cancer. 2018 Oct;102:69-81. https://doi.org/10.1016/j.ejca.2018.07.006 |
|
The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. | Brown MC et al. | Pediatr Blood Cancer. 2015 Feb;62(2):322-328. https://doi.org/10.1002/pbc.25310 |
|
Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. | Bright CJ et al. | J Natl Cancer Inst. 2018 Jun 1;110(6):649-660. https://doi.org/10.1093/jnci/djx235 |
|
Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. | Fidler MM et al. | J Natl Cancer Inst. 2018 Feb 1;110(2). https://doi.org/10.1093/jnci/djx165 |
|
The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. | Brown MC et al. | Pediatr Blood Cancer. 2015 Feb;62(2):322-328. https://doi.org/10.1002/pbc.25310 |
|
Recommendations for Cardiomyopathy Surveillance for Survivors of Childhood Cancer: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. | Armenian SH et al. | Lancet Oncology 2015; 16: e123-136. https://doi.org/10.1016/s1470-2045(14)70409-7 |
|
The European Experience of Establishing Guidelines for Surveillance of the Childhood Cancer Survivor, in Handbook of Long Term Care of the Childhood Cancer Survivor. | Skinner R et al. |
In Handbook of Long-Term Care of the Childhood Cancer Survivor; Mucci, G., Torno, L., Eds.;
Springer: New York, NY, USA, 2015; pp. 25–35
|
|
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care. | Hjorth L et al. | Eur J Cancer, 2015. 51(10): 1203-1211. https://doi.org/10.1016/j.ejca.2015.04.002 |
|
Surveillance of late effects by treatment: the European experience. | Skinner R et al. | Handbook of Long Term Care of the Childhood Cancer Survivor”, ed GA Mucci. | |
A New Method to Facilitate Valid and Consistent Grading Cardiac Events in Childhood Cancer Survivors Using Medical Records | Feijen EL et al. | PLoS One. 2014; 9(7): e100432. https://doi.org/10.1371/journal.pone.0100432 |
|
Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment. | Schwartz B et al. | Radiat Environ Biophys, 2014. 53(2): 381-90. https://doi.org/10.1007/s00411-013-0510-9 |
|
REPORT: Handbook for guideline development; collaboration between International Guideline Harmonization Group, PanCareSurFup and Cochrane Childhood Cancer Group. | Mulder RL et al. | ||
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. | Kremer LC et al. | Pediatr Blood Cancer, 2013. 60(4): 543-9. https://doi.org/10.1002/pbc.24445 |
|
Developing international consensus for late effects screening and guidance. | Skinner R et al. | Current Opinion in Supportive and Palliative Care 7(3):p 303-308, September 2013. https://doi.org/10.1097/SPC.0b013e328363a607 |
|
Health problems in survivors of childhood cancer: the need for international collaboration in long-term follow-up care | Mulder RL et al. | Future Oncol. 2013 Nov;9(11):1667-70 https://doi.org/10.2217/fon.13.107 |
|
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group | Mulder RL et al. | Lancet Oncol, 2013. 14(13): e621-9. https://doi.org/10.1016/S1470-2045(13)70303-6 |
|
Transitional care of a childhood cancer survivor to adult services, facilitating the process of individual access to different models | Frey E et al. | Curr Opin Support Palliat Care. 2013 Sep;7(3):309-13. https://doi.org/10.1097/SPC.0b013e32836484bb |
|
Cohort profile: The Swiss Childhood Cancer Survivor Study. | Kuehni CE et al. | Int J Epidemiol,2012. 41(6): 1553-1564. https://doi.org/10.1093/ije/dyr142 |
|
Total heart volume as a function of clinical and anthropometric parameters in a population of external beam radiation therapy patients | Badouna AN et al. | Phys Med Biol. 2012 Jan 21;57(2):473-84 https://doi.org/10.1088/0031-9155/57/2/473 |